Latest Manufacturing News

Page 203 of 217
Aeris Environmental Ltd reported a 5% revenue increase to $766,000 in the December 2024 quarter, driven by strong margins and momentum in its AerisTech joint venture. The company’s expanding customer base and strategic partnerships signal promising growth in smart building solutions and consumables.
Victor Sage
Victor Sage
31 Jan 2025
Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.
Victor Sage
Victor Sage
31 Jan 2025
4DS Memory Limited reports successful testing of its 60nm memory cells and progresses toward 20nm technology, alongside a $6 million capital raise and a new design partnership with Infineon.
Victor Sage
Victor Sage
31 Jan 2025
Zimi Limited has secured $2.495 million through a capital raising, appointed new board members, and initiated cost-saving measures exceeding $400,000 annually, while navigating a compliance issue affecting sales to a major distributor.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Australian Vanadium Limited reports significant progress in its integrated vanadium supply chain, including government approvals, Project Lumina development, and successful vanadium flow battery deployment.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.
Ada Torres
Ada Torres
31 Jan 2025
Osteopore Limited reports a robust 27% year-over-year revenue increase despite operational headwinds, underpinned by new collaborations in stem cell therapies and expanded market access in Brazil and Singapore.
Ada Torres
Ada Torres
31 Jan 2025
Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.
Ada Torres
Ada Torres
31 Jan 2025
Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.
Victor Sage
Victor Sage
31 Jan 2025
Ecofibre Limited reports a mixed financial performance for Q2 2025, highlighting significant debt reduction efforts and strategic restructuring to return to positive cash flows.
Victor Sage
Victor Sage
31 Jan 2025
Constellation Technologies reports a slight decline in quarterly sales but marks a strategic breakthrough by deploying its Callisto Food Safety & Compliance system into the Aged Care sector, positioning itself for growth in a highly regulated market.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Li-S Energy has set a new benchmark in lithium-sulfur battery technology, achieving a record 456Wh/kg energy density and successfully powering its first UAV test flights, signaling strong momentum in sustainable battery innovation.
Maxwell Dee
Maxwell Dee
31 Jan 2025